Task: Answer the multiple choice question.
Query: Which drug has a -18.115% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. COCCNc1nc2c(-c3cccc(C(F)(F)F)c3)nnn2c2ccccc12
b. O=C(CSCc1ccc(Br)cc1)Nc1ccc(S(=O)(=O)N2CCOCC2)cc1
c. CCC(=O)NCCc1nc2cc(NC(=O)c3ccc(Cl)cc3)ccc2n1C
Answer: c. CCC(=O)NCCc1nc2cc(NC(=O)c3ccc(Cl)cc3)ccc2n1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)NCCc1nc2cc(NC(=O)c3ccc(Cl)cc3)ccc2n1C
CCC(=O)NCCc1nc2cc(NC(=O)c3ccc(Cl)cc3)ccc2n1C
4-chloro-N-[1-methyl-2-[2-(propanoylamino)ethyl]benzimidazol-5-yl]benzamide